Cargando…

Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review

BACKGROUND: Chronic heart failure (CHF) is a global public health problem. Therefore, novel and effective drugs that show few side-effects are needed. Early literature studies indicated that Huangqi injection is one of the most commonly used traditional Chinese patent medicines for CHF in China. As...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Shufei, Zhang, Junhua, Menniti-Ippolito, Francesca, Gao, Xiumei, Galeotti, Francesca, Massari, Marco, Hu, Limin, Zhang, Boli, Ferrelli, Rita, Fauci, Alice, Firenzuoli, Fabio, Shang, Hongcai, Guerra, Ranieri, Raschetti, Roberto
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089614/
https://www.ncbi.nlm.nih.gov/pubmed/21573109
http://dx.doi.org/10.1371/journal.pone.0019604
_version_ 1782203063098933248
author Fu, Shufei
Zhang, Junhua
Menniti-Ippolito, Francesca
Gao, Xiumei
Galeotti, Francesca
Massari, Marco
Hu, Limin
Zhang, Boli
Ferrelli, Rita
Fauci, Alice
Firenzuoli, Fabio
Shang, Hongcai
Guerra, Ranieri
Raschetti, Roberto
author_facet Fu, Shufei
Zhang, Junhua
Menniti-Ippolito, Francesca
Gao, Xiumei
Galeotti, Francesca
Massari, Marco
Hu, Limin
Zhang, Boli
Ferrelli, Rita
Fauci, Alice
Firenzuoli, Fabio
Shang, Hongcai
Guerra, Ranieri
Raschetti, Roberto
author_sort Fu, Shufei
collection PubMed
description BACKGROUND: Chronic heart failure (CHF) is a global public health problem. Therefore, novel and effective drugs that show few side-effects are needed. Early literature studies indicated that Huangqi injection is one of the most commonly used traditional Chinese patent medicines for CHF in China. As a large number of clinical studies has been carried out and published, it is essential to evaluate the effectiveness and safety of Huangqi injection. Therefore, we carried out this systematic review under the support of the framework of the Joint Sino-Italian Laboratory (JoSIL). OBJECTIVES: To evaluate the efficacy and safety of Huangqi injection for CHF according to the available scientific knowledge. METHODS: An extensive search including PubMed, EMBASE, CBM, the Cochrane Library and Chinese literature databases was performed up to July 2008. Clinical trials regarding Huangqi injection for the treatment of CHF were searched for, irrespective of languages. The quality of each trial was assessed according to the Cochrane Reviewers' Handbook 5.0, and RevMan 5.0 provided by the Cochrane Collaboration and STATA 9.2 were used for data analysis. RESULTS: After selection of 1,205 articles, 62 RCTs and quasi-RCTs conducted in China and published in Chinese journals were included in the review. The methodological quality of the trials was low. In most trials inclusion and exclusion criteria were not specified. Furthermore, only one study evaluated the outcomes for drug efficacy after an adequate period of time. For these reasons and because of the different baseline characteristics we did not conduct a meta-analysis. CONCLUSIONS: Although available studies are not adequate to draw a conclusion on the efficacy and safety of Huangqi injection (a traditional Chinese patent medicine), we hope that our work could provide useful experience on further studies on Huangqi injections. The overall level of TCM clinical research needs to be improved so that the efficacy of TCM can be evaluated by the international community and possibly some TCM can enter into the international market.
format Text
id pubmed-3089614
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-30896142011-05-13 Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review Fu, Shufei Zhang, Junhua Menniti-Ippolito, Francesca Gao, Xiumei Galeotti, Francesca Massari, Marco Hu, Limin Zhang, Boli Ferrelli, Rita Fauci, Alice Firenzuoli, Fabio Shang, Hongcai Guerra, Ranieri Raschetti, Roberto PLoS One Research Article BACKGROUND: Chronic heart failure (CHF) is a global public health problem. Therefore, novel and effective drugs that show few side-effects are needed. Early literature studies indicated that Huangqi injection is one of the most commonly used traditional Chinese patent medicines for CHF in China. As a large number of clinical studies has been carried out and published, it is essential to evaluate the effectiveness and safety of Huangqi injection. Therefore, we carried out this systematic review under the support of the framework of the Joint Sino-Italian Laboratory (JoSIL). OBJECTIVES: To evaluate the efficacy and safety of Huangqi injection for CHF according to the available scientific knowledge. METHODS: An extensive search including PubMed, EMBASE, CBM, the Cochrane Library and Chinese literature databases was performed up to July 2008. Clinical trials regarding Huangqi injection for the treatment of CHF were searched for, irrespective of languages. The quality of each trial was assessed according to the Cochrane Reviewers' Handbook 5.0, and RevMan 5.0 provided by the Cochrane Collaboration and STATA 9.2 were used for data analysis. RESULTS: After selection of 1,205 articles, 62 RCTs and quasi-RCTs conducted in China and published in Chinese journals were included in the review. The methodological quality of the trials was low. In most trials inclusion and exclusion criteria were not specified. Furthermore, only one study evaluated the outcomes for drug efficacy after an adequate period of time. For these reasons and because of the different baseline characteristics we did not conduct a meta-analysis. CONCLUSIONS: Although available studies are not adequate to draw a conclusion on the efficacy and safety of Huangqi injection (a traditional Chinese patent medicine), we hope that our work could provide useful experience on further studies on Huangqi injections. The overall level of TCM clinical research needs to be improved so that the efficacy of TCM can be evaluated by the international community and possibly some TCM can enter into the international market. Public Library of Science 2011-05-06 /pmc/articles/PMC3089614/ /pubmed/21573109 http://dx.doi.org/10.1371/journal.pone.0019604 Text en Fu et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Fu, Shufei
Zhang, Junhua
Menniti-Ippolito, Francesca
Gao, Xiumei
Galeotti, Francesca
Massari, Marco
Hu, Limin
Zhang, Boli
Ferrelli, Rita
Fauci, Alice
Firenzuoli, Fabio
Shang, Hongcai
Guerra, Ranieri
Raschetti, Roberto
Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review
title Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review
title_full Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review
title_fullStr Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review
title_full_unstemmed Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review
title_short Huangqi Injection (a Traditional Chinese Patent Medicine) for Chronic Heart Failure: A Systematic Review
title_sort huangqi injection (a traditional chinese patent medicine) for chronic heart failure: a systematic review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089614/
https://www.ncbi.nlm.nih.gov/pubmed/21573109
http://dx.doi.org/10.1371/journal.pone.0019604
work_keys_str_mv AT fushufei huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT zhangjunhua huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT mennitiippolitofrancesca huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT gaoxiumei huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT galeottifrancesca huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT massarimarco huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT hulimin huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT zhangboli huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT ferrellirita huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT faucialice huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT firenzuolifabio huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT shanghongcai huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT guerraranieri huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT raschettiroberto huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview